IP Verse

Adalvo Ltd. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Adalvo Ltd.

Patent Number:
EP3542790
Title:
Compositions Comprising A Delivery Agent And Preparation Thereof
Applicant:
NOVO NORDISK A/S
Opposition Date:
Jun 13, 2024
Patent Number:
EP3697392
Title:
Tablets Comprising Tamsulosin And Solifenacin
Applicant:
SYNTHON B.V.
Opposition Date:
Jan 23, 2024
Patent Number:
EP3283058
Title:
Ribociclib Tablet
Applicant:
NOVARTIS AG
Opposition Date:
Aug 15, 2023
Patent Number:
EP2981255
Title:
Therapeutic Uses Of Empagliflozin
Applicant:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Opposition Date:
Jun 13, 2023
Patent Number:
EP3448416
Title:
Semaglutide In Cardiovascular Conditions
Applicant:
NOVO NORDISK A/S
Opposition Date:
May 9, 2023
Patent Number:
EP2653873
Title:
Compositions And Uses For Treating Multiple Sclerosis
Applicant:
BIOGEN IDEC MA INC.
Opposition Date:
Apr 14, 2023
Patent Number:
EP3632448
Title:
Pharmaceutical Composition Comprising Drospirenone And Contraceptive Kit
Applicant:
LABORATORIOS LEON FARMA SA
Opposition Date:
Oct 12, 2022
Patent Number:
EP3423082
Title:
Liraglutide In Cardiovascular Conditions
Applicant:
NOVO NORDISK A/S
Opposition Date:
May 3, 2022
Patent Number:
EP3253377
Title:
Monomethylfumarate Prodrug Compositions
Applicant:
ALKERMES PHARMA IRELAND LIMITED
Opposition Date:
Feb 7, 2022
Patent Number:
EP3246017
Title:
Stable Liquid Formulation Of Amg 416 Hcl (Etelcalcetide)
Applicant:
AMGEN INC.
Opposition Date:
Dec 22, 2021

Competitors of Adalvo Ltd.

NOVO NORDISK A/S

ALKERMES PHARMA IRELAND LIMITED

AMGEN INC.

Want to track Adalvo Ltd.?

Feel free to send us a message here and we will get back to you